FACULTAD DE MEDICINA
Facultad
Ricardo
Blanco Alonso
Publicaciones en las que colabora con Ricardo Blanco Alonso (90)
2023
-
Corrigendum: The paradigm of IL-23-independent production of IL-17F and IL-17A and their role in chronic inflammatory diseases(Front. Immunol., (2023), 14, (1191782), 10.3389/fimmu.2023.1191782)
Frontiers in Immunology
-
Cranial and extracranial giant cell arteritis do not exhibit differences in the IL6 -174 G/C gene polymorphism
Clinical and experimental rheumatology, Vol. 41, Núm. 4, pp. 910-915
-
Cranial and extracranial large-vessel giant cell arteritis share a genetic pattern of interferon-gamma pathway
Clinical and experimental rheumatology, Vol. 41, Núm. 4, pp. 864-869
-
Ocular involvement in adult and paediatric patients with monogenic autoinflammatory diseases: a Spanish multicentre retrospective study
Clinical and experimental rheumatology, Vol. 41, Núm. 10, pp. 2105-2114
-
Optimisation of tocilizumab therapy in giant cell arteritis. A multicentre real-life study of 471 patients
Clinical and experimental rheumatology, Vol. 41, Núm. 4, pp. 829-836
-
The complex HLA-E-nonapeptide in Behçet disease
Frontiers in Immunology, Vol. 14
-
The paradigm of IL-23-independent production of IL-17F and IL-17A and their role in chronic inflammatory diseases
Frontiers in Immunology, Vol. 14
2022
-
Biologic therapy in refractory neurobehçet's disease: a multicentre study of 41 patients and literature review
Rheumatology (Oxford, England), Vol. 61, Núm. 11, pp. 4427-4436
-
IgA Vasculitis: Influence of CD40, BLK and BANK1 Gene Polymorphisms
Journal of Clinical Medicine, Vol. 11, Núm. 19
-
Intravenous methylprednisolone induces rapid improvement in non-infectious uveitis: a multicentre study of 112 patients
Clinical and Experimental Rheumatology
-
Tocilizumab in visual involvement of giant cell arteritis: a multicenter study of 471 patients
Therapeutic Advances in Musculoskeletal Disease, Vol. 14
-
Vascular endothelial growth factor haplotypes are associated with severe ischaemic complications in giant cell arteritis regardless of the disease phenotype
Clinical and experimental rheumatology, Vol. 40, Núm. 4, pp. 727-733
2021
-
Author Correction: BAFF, APRIL and BAFFR on the pathogenesis of Immunoglobulin-A vasculitis (Scientific Reports, (2021), 11, 1, (11510), 10.1038/s41598-021-91055-z)
Scientific Reports
-
BAFF, APRIL and BAFFR on the pathogenesis of Immunoglobulin-A vasculitis
Scientific Reports, Vol. 11, Núm. 1
-
Cranial and extracranial giant cell arteritis do not have different HLA-DRB1 and HLA-B association in Caucasian individuals
Arthritis Research and Therapy
-
Long-term Follow-up and optimization of infliximab in refractory uveitis due to Behçet Disease: National study of 103 white patients
Journal of Rheumatology, Vol. 48, Núm. 5, pp. 741-750
-
Role of the IL33 and IL1RL1 pathway in the pathogenesis of Immunoglobulin A vasculitis
Scientific Reports, Vol. 11, Núm. 1
-
Tocilizumab in refractory Caucasian Takayasu’s arteritis: a multicenter study of 54 patients and literature review
Therapeutic Advances in Musculoskeletal Disease, Vol. 13
2020
-
Biologic therapy in refractory non-multiple sclerosis optic neuritis isolated or associated to immune-mediated inflammatory diseases. A multicenter study
Journal of Clinical Medicine, Vol. 9, Núm. 8, pp. 1-13
-
Influence of IL17A gene on the pathogenesis of immunoglobulin-A vasculitis
Clinical and experimental rheumatology, Vol. 38, Núm. 2, pp. 166-170